HSP90AB1 and Parkinson disease: We show here that S-HSP90 chaperome network inhibition can attenuate the over-activation of such PD-related pathways, and it remains to be investigated if altering the stable HSP90-chaperome networks via PU-H71 type compounds may be beneficial in in vivo PD models, and ultimately the human setting.